Table 2.
Results of QTL mapping at three developmental stages (PH1-PH3) and fivefold cross-validation
| PH1 | PH2 | PH3 | |
|---|---|---|---|
| QTLDS |
15 |
18 |
8 |
|
pG-DS |
77.7 |
78.3 |
73.1 |
| QTLES |
14.4 |
13.1 |
7.8 |
|
pG-ES |
77.2 |
76.1 |
70.4 |
|
pG-TS |
55.3 |
58.2 |
56.0 |
| Relative bias | 28.4 | 23.5 | 20.5 |
Number of detected QTL (QTLDS), proportion of genotypic variance (%) explained by the detected QTL across all families in the data set (pG-DS), number of QTL (QTLES) and proportion of genotypic variance averaged over estimation sets (pG-ES) and averaged over test sets (pG-TS), and relative bias (%) in the estimation of pG.